Highlights From GILD's Q4 Conference Call: Q4 Crossed $2 Billion Mark for First Time in Company History
Tweet Send to a Friend
Gilead Sciences (NASDAQ: GILD) reports Q4 EPS of $0.93, 8 cents better than the analyst estimate of $0.85. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
